RHAPSIDO® (remibrutinib) safety in clinical trials
RHAPSIDO safety results
The safety data of RHAPSIDO have been studied in 2 clinical trials, and reviewing these results can help you make an informed decision about your treatment.
The most common side effects with RHAPSIDO include:
Nasopharyngitis (nasal congestion, sore throat, and runny nose): 11% of those who took RHAPSIDO and 9% who took placebo
Bleeding: 9% of those who took RHAPSIDO and 2% who took placebo; of the 9%, the most common types of bleeding were tiny red spots on the skin (4%) and bruising (2%)
Headache: 7% of those who took RHAPSIDO and 6% who took placebo
Nausea: 3% of those who took RHAPSIDO and 2% who took placebo
Abdominal pain: 3% of those who took RHAPSIDO and 2% who took placebo
These are not all of the possible side effects.
Proven relief from hives and itch
In clinical trials, people taking RHAPSIDO found relief from chronic hives with no known external triggers when antihistamines alone weren’t enough. RHAPSIDO should not be used to treat any other forms of hives.
The ultimate guide to RHAPSIDO
